Comparison

itacitinib-adipate

Item no. V0066-500mg
Manufacturer InvivoChem LLC
CASRN 1334302-63-4
Amount 500mg
Category
Type Biochemicals
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Description
InvivoChem Cat #:V0066CAS #:1334302-63-4Purity >=98%

Description: Itacitinib adipate, the adipate salt of itacitinib which is also known as INCB39110, is a potent, selective and orally bioavailable inhibitor of JAK1 (Janus-associated kinase 1) with potential antineoplastic activity, currently in Phase II clinical trials for the treatment of myelofibrosis, rheumatoid arthritis and plaque psoriasis.

Description:

References: 2017 Feb; 102(2):327-335; 2017 Feb; 27(2):127-143; AACR; Cancer Res. 2015, 75(15 Suppl).

References:

Related CAS: 1334298-90-6 (free base) 1334302-63-4 (adipate salt)

Molecular Weight (MW)
699.66
Formula
C??H??F?N?O?
CAS No.
1334302-63-4 (adipate salt)
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Solubility (In vitro)
DMSO: > 90 mg/mL
Water: N/A
Ethanol: > 90 mg/mL
Chemical Name
2-(3-(4-(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(1-(3-fluoro-2-(trifluoromethyl)isonicotinoyl) piperidin-4-yl)azetidin-3-yl)acetonitrile adipate
Synonyms
INCB039110; INCB-039110; INCB 039110; INCB39110; INCB 39110; INCB-39110
SMILES Code
N#CCC1(N2N=CC(C3=C4C(NC=C4)=NC=N3)=C2)CN(C5CCN(C(C6=C(F)C(C(F)(F)F)=NC=C6)=O)CC5)C1 .O=C(O)CCCCC(O)=O

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close